ClinVar Miner

Submissions for variant NM_024009.3(GJB3):c.298G>A (p.Glu100Lys)

dbSNP: rs1028370381
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000490186 SCV000577607 likely pathogenic not provided 2016-07-27 criteria provided, single submitter clinical testing The E100K missense variant in the GJB3 gene has been reported previously in association with Erythrokeratodermia Variabilis (EKV) in an individual who was homozygous for the variant (Terrinoni et al., 2004). Heterozygous relatives were unaffected in that family. E100K was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. E100K is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved in mammals. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. A missense variant in a nearby residue (R101Q) havs been reported in the Human Gene Mutation Database in association with EKV (Stenson et al., 2014). Therefore, we consider this variant to be likely pathogenic for autosomal recessive EKV.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.